Christian D Podder Since 2020 Risks and uncertainties include, but are not limited to adverse changes in general economic conditions as well as risks associated with public health crises and pandemics, such as the COVID-19 global pandemic, government actions and restrictive measures implemented in response, supply chain disruptions, delays in clinical trials, and other impacts to the business, our customers, suppliers, and employees; dependence on a principal product platform; ability to maintain and grow o ...

Matt, itÂ's Wayde. Happy to take that and I think Jim covered it well, but maybe just a couple things I could add to that. I think as Jim said, one of the best indicators we have is that there are some type 1 endocrinologists that are already have more than 70% of their type 1s on a pump. So thatÂ's a clear early indicator. But itÂ's a great question on the rate of change. WeÂ'll see how that market develops. The good news is we have many other growth platforms, obviously our leadership position in type 2 i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________ Form 10-Q _____________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-33462 ___________________________________________________________ ...

Thanks, Deb. Good afternoon, and thank you for joining us. In Q4, the global Insulet team delivered another record quarter of growth, which was a strong end cap to a remarkable 2022. We exceeded our expectations once again, achieving revenue growth of 45% in the U.S. and over 35% for total Omnipod and our U.S. and global new customer starts were at record levels. And 2022 marked our seventh consecutive year of 20-plus percent Insulet Corporation (NASDAQ:PODD) Q4 2022 Results Conference Call February 23, 202 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year endedDecember 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-33462 INSULET CORPORATION (Exact name of Registrant as specified in its charter) Delaware 04-3523891 (State or Other Jurisdiction of (I.R.S. Employe ...

Insulet Corporation (NASDAQ:PODD) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President and Chief Executive Officer Wayde McMillan - Executive Vice President and Chief Financial Officer Bret Christensen - Executive Vice President and Chief Commercial Officer Conference Call Participants Jeff Johnson - Baird Travis Steed - Bank of America Securities Robbie Marcus - JPMorgan Margaret Kaczor - William B ...

Insulet Corporation (NASDAQ:PODD) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President and Chief Executive Officer Wayde McMillan - Executive Vice President and Chief Financial Officer Bret Christensen - Executive Vice President and Chief Commercial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JP Morgan Travis Steed - Bank of America Steve Lichtman - Oppenheimer C ...

Insulet Corporation (NASDAQ:PODD) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Shacey Petrovic - President, CEO and Director Jim Hollingshead - Member of Board of Directors and Insulet's future President and CEO Wayde McMillan - Executive VP,CFO and Treasurer Bret Christensen - Executive VP and Chief Commercial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JPMorgan Travis Steed - Bank of ...

Insulet Corporation (NASDAQ:PODD) Q4 2021 Earnings Conference Call February 23, 2022 4:30 PM ET Company Participants Deborah Gordon - VP, IR Shacey Petrovic - President & CEO Wayde McMillan - EVP & CFO Bret Christensen - EVP & Chief Commercial Officer Conference Call Participants Jayson Bedford - Raymond James Robbie Marcus - JP Morgan Lawrence Biegelsen - Wells Fargo Jeff Johnson - Baird Joanne Wuensch - Citi Danielle Antalffy - SVB Leerink Matt Taylor - UBS Steve Lichtman - Oppenheimer Matthew O'Brien - P ...

Insulet Corporation (NASDAQ:PODD) Q3 2021 Results Conference Call November 4, 2021 4:30 PM ET Company Participants Deborah Gordon - VP, IR Shacey Petrovic - President and CEO Wayde McMillan - EVP and CFO Bret Christensen - EVP and Chief Commercial Officer Conference Call Participants Margaret Kaczor - William Blair Robbie Marcus - JP Morgan Danielle Antalffy - SVB Leerink Lawrence Biegelsen - Wells Fargo Jeff Johnson - Baird Matt Taylor - UBS Travis Steed - Barclays Jayson Bedford - Raymond James Cecilia Fu ...